Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

116.44 +0.52 (+0.45%)
Streaming Delayed Price Updated: 10:05 AM EDT, Aug 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 414,904
Open 115.95
Bid (Size) 116.43 (4)
Ask (Size) 116.50 (6)
Prev. Close 115.92
Today's Range 115.75 - 116.56
52wk Range 96.06 - 124.83
Shares Outstanding N/A
Dividend Yield 3.43%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Brilliant Vanguard Index Funds to Buy With $1,000 in August and Hold Forever
These Vanguard index funds offer diversified exposure to many of the most influential stocks in the world. 
Via The Motley Fool
Topics ETFs
PTCT Earnings Beat but Sales Drop 4%
Via The Motley Fool
Topics Earnings

Performance

YTD
+19.9%
+19.9%
1 Month
-4.3%
-4.3%
3 Month
+5.7%
+5.7%
6 Month
+8.8%
+8.8%
1 Year
+4.7%
+4.7%

More News

Read More
Monte Rosa (GLUE) Q2 Revenue Jumps 394%
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
Schrödinger (SDGR) Q2 2025 Earnings Transcript
Via The Motley Fool
Novartis Reportedly Eyeing To Acquire Avidity Biosciences: But Retail Expects Management To Sell Only At Significant Premium
Via Stocktwits
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful
Via Stocktwits
Topics Earnings
Avidity Biosciences Rockets As Novartis Reportedly Mulls A Takeover Deal
Via Investor's Business Daily
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Hazelden Betty Ford Foundation Appoints Four New Members to Its Board of Trustees
Via Newsfile
15 regions chosen for groundbreaking effort to reduce cardiovascular disease
Via NewMediaWire
3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs
Via Benzinga
Topics Economy Government World Trade
Sarepta Gets Thumbs Down From Regulators Regarding Elevidys Gene Therapy
Via Benzinga
U.S. Current-Account Deficit Widens to $450 Billion Amid Trade Imbalances and Energy Imports
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
NOVARTIS AG-SPONSORED ADR (NYSE:NVS): A Top Dividend Stock with Strong Profitability and Financial Stability
Via Chartmill
The Hits Keep Coming For Sarepta. Why Its Latest Setback Creates A 'Dangerous Precedent' For Gene Therapies.
Via Investor's Business Daily
Topics Death Workforce
Screening for cardiovascular disease marker in community health centers may reduce risk
Via NewMediaWire
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US
Via Benzinga
Topics Government
Highest Ever for This International Stock ETF -- But Analysts Say It Has Room to Run
Via The Motley Fool
Topics ETFs World Trade
AstraZeneca Bets Big On America With $50B Investment, New Virginia Hub Plans Amid Pharma Tariff Jitters
Via Stocktwits
Topics Artificial Intelligence Government World Trade
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
Via The Motley Fool
Topics Government World Trade
NOVARTIS AG-SPONSORED ADR (NYSE:NVS) – A Potentially Undervalued Stock With Strong Fundamentals
Via Chartmill
Novartis Makes A Bearish Move As One Of Its Bread-And-Butter Drugs Misses
Via Investor's Business Daily
Topics Government Stocks
Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback
Via Benzinga
Earnings Scheduled For July 17, 2025
Via Benzinga

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 116.44
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 08/08/25 10:05 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.